308.62
0.07%
+0.1678
AMGEN Inc. (AMGN) 最新ニュース
Best Inverse/Leveraged ETFs of Last Week
Zacks Investment Research
The Zacks Analyst Blog Highlights Amgen, Amazon.com, Apple, Boeing and Goldman Sachs
Zacks Investment Research
My Dividend Growth Portfolio: Selling Bio-Pharma And Buying More Big-Tech
Seeking Alpha
Amgen Is Working On a Wegovy Competitor -- What It Means for Investors
The Motley Fool
5 Stocks Driving Dow's Market-Beating Performance
Zacks Investment Research
Wall Street Stares At Weaker Open On Rate Anxiety, Hopes For Better Earnings: Analyst Pencils Key S&P 500 Support Level
Benzinga
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
Zacks Investment Research
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Zacks Investment Research
Company News for May 6, 2024
Zacks Investment Research
Cathie Wood's Ark Invest Snaps Up $3.54M Worth Of Shares In This Biopharma Company Following Positive Obesity Pipeline Update
Benzinga
SCHD: A Must-Have In Every Dividend Portfolio
Seeking Alpha
Why Amgen Stock Zoomed Nearly 12% Higher Today
The Motley Fool
Stocks Rally As Jobs Report Rekindles Rate Cut Hopes, Apple Rockets, Bitcoin Soars Above $61,000: What's Driving Markets Friday?
Benzinga
Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
Zacks Investment Research
Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug Potential Will Drive Shareholder Value
Benzinga
Wage Growth Slows – Stock Market Celebrates, Five Real Reasons Apple Is Running Up
Benzinga
Wall Street Looks To Feed Off Apple's Post-Earnings Power But Key Jobs Data May Upset The Cart: Analyst Says 'A Lot Of These Clouds Will Lift' If This Happens
Benzinga
Here's What Key Metrics Tell Us About Amgen (AMGN) Q1 Earnings
Zacks Investment Research
Wall Street Inches Up After Powell's Inflation Remarks; Chipmakers Rebound; Gold, Crude Falter: What's Driving Markets Thursday?
Benzinga
Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market
Benzinga
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
Zacks Investment Research
What's in the Cards for Amgen (AMGN) This Earnings Season?
Zacks Investment Research
Insights Into Amgen (AMGN) Q1: Wall Street Projections for Key Metrics
Zacks Investment Research
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
Zacks Investment Research
Wall Street Breakfast: The Week Ahead
Seeking Alpha
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
Zacks Investment Research
Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for
Zacks Investment Research
Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?
Benzinga
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
Zacks Investment Research
Better Buy: Pfizer vs. Viking Therapeutics
The Motley Fool
1 No-Brainer Vanguard Fund to Buy Right Now
The Motley Fool
Why Amgen (AMGN) Outpaced the Stock Market Today
Zacks Investment Research
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
Zacks Investment Research
SCHD: If You've Won The Game, Take A Little Off The Top
Seeking Alpha
Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies
Zacks Investment Research
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights
Zacks Investment Research
Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick
Benzinga
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Benzinga
Can This High-Yield Dividend Stock Keep Beating the S&P 500?
The Motley Fool
Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever
The Motley Fool
Should You Invest in the VanEck Biotech ETF (BBH)?
Zacks Investment Research
Amgen (AMGN) Laps the Stock Market: Here's Why
Zacks Investment Research
Is Amgen Stock a Buy?
The Motley Fool
Rose's Income Garden Portfolio With 7 March Dividend Raises/ Portfolio Yield 6%
Seeking Alpha
Biophytis (BPTS) to Begin Phase II Obesity Study, Stock Up
Zacks Investment Research
3 Top Dividend Stocks to Maximize Your Retirement Income
Zacks Investment Research
2 Biotech Stocks to Buy Hand Over Fist in April
The Motley Fool
Amgen (AMGN) Ascends But Remains Behind Market: Some Facts to Note
Zacks Investment Research
Building A $1.4 Million Retirement Fund: 4 Stocks Yielding Up To 6% To Get The Job Done
Seeking Alpha
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Zacks Investment Research
大文字化:
|
ボリューム (24 時間):